Ajanta Pharma Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Coforge Ltd, Piramal Pharma Ltd, Kansai Nerolac Paints Ltd, Elgi Equipments Ltd are among the other stocks to see a surge in volumes on NSE today, 03 May 2024.

Ajanta Pharma Ltd notched up volume of 22.6 lakh shares by 14:14 IST on NSE, a 19.26 fold spurt over two-week average daily volume of 1.17 lakh shares. The stock rose 7.63% to Rs.2,404.35. Volumes stood at 83782 shares in the last session.

Coforge Ltd recorded volume of 41.14 lakh shares by 14:14 IST on NSE, a 12.86 times surge over two-week average daily volume of 3.20 lakh shares. The stock lost 9.64% to Rs.4,505.20. Volumes stood at 4.49 lakh shares in the last session.

Piramal Pharma Ltd recorded volume of 234.92 lakh shares by 14:14 IST on NSE, a 9.98 times surge over two-week average daily volume of 23.53 lakh shares. The stock gained 5.16% to Rs.150.75. Volumes stood at 13.07 lakh shares in the last session.

Kansai Nerolac Paints Ltd saw volume of 22.16 lakh shares by 14:14 IST on NSE, a 9.87 fold spurt over two-week average daily volume of 2.24 lakh shares. The stock increased 2.80% to Rs.294.05. Volumes stood at 4.51 lakh shares in the last session.

Elgi Equipments Ltd saw volume of 16.49 lakh shares by 14:14 IST on NSE, a 6.91 fold spurt over two-week average daily volume of 2.39 lakh shares. The stock dropped 0.61% to Rs.654.30. Volumes stood at 3.05 lakh shares in the last session.

Powered by Capital Market - Live News

Coforge Ltd, Cummins India Ltd, Torrent Pharmaceuticals Ltd, Bajaj Finserv Ltd are among the other stocks to see a surge in volumes on BSE today, 03 May 2024.

Ajanta Pharma Ltd witnessed volume of 39704 shares by 10:46 IST on BSE, a 10.56 times surge over two-week average daily volume of 3761 shares. The stock increased 7.12% to Rs.2,392.00. Volumes stood at 7252 shares in the last session.

Coforge Ltd recorded volume of 89225 shares by 10:46 IST on BSE, a 6.46 times surge over two-week average daily volume of 13815 shares. The stock lost 8.78% to Rs.4,548.55. Volumes stood at 7518 shares in the last session.

Cummins India Ltd recorded volume of 29005 shares by 10:46 IST on BSE, a 3.57 times surge over two-week average daily volume of 8118 shares. The stock gained 2.97% to Rs.3,402.05. Volumes stood at 8627 shares in the last session.

Torrent Pharmaceuticals Ltd clocked volume of 8359 shares by 10:46 IST on BSE, a 3.24 times surge over two-week average daily volume of 2582 shares. The stock gained 3.58% to Rs.2,769.40. Volumes stood at 1063 shares in the last session.

Bajaj Finserv Ltd registered volume of 1.76 lakh shares by 10:46 IST on BSE, a 2.79 fold spurt over two-week average daily volume of 63098 shares. The stock rose 1.64% to Rs.1,642.45. Volumes stood at 52656 shares in the last session.

Powered by Capital Market - Live News

Profit before tax soared 82.86% to Rs 278.04 crore in Q4 FY24 from Rs 152.05 crore reported in the same period a year ago.

EBITDA in Q4 FY24 was at Rs 278 crore, registering a growth of 86% year on year (YoY). EBITDA margin improved to 26% in the March quarter as compared to17% registered in Q4 FY23.

During the quarter, the company’s revenue from India stood at Rs 326 crore (up 14% YoY), revenue from Asia was at Rs 281 crore ( up 18% YoY), income from Africa stood at Rs 113 crore (up 13% YoY) while revenue from United States was at Rs 261 crore ( up 32% YoY).

Research and development (R&D) expenses were at Rs 50 crore in Q4 FY24, down 20.63% as against Rs 63 crore posted in Q4 FY23.

On full year basis, the company’s consolidated net profit surged 38.81% to Rs 816.17 crore on 12.45% rise in revenue to Rs 4,208.71 crore in FY24 over FY23.

Meanwhile, the pharmaco said that its board has approved a share buyback of upto Rs 285 crore at a price of Rs 2,770 per equity share through tender offer route.

The buyback price fixed at Rs 2,770 per equity share, representing a 24.04% premium to Thursday’s closing price of Rs 2,233.10 on the BSE.

The company will buyback up to 10,28,881 fully paid-up equity shares, representing 0.82% of the total paid-up equity shares of the company.

Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified branded generics business spread across India, the Rest of Asia, and Africa. The company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets. It produces a comprehensive range of specialty products targeting different therapeutic segments.

Powered by Capital Market - Live News

Net profit of Ajanta Pharma rose 65.82% to Rs 202.72 crore in the quarter ended March 2024 as against Rs 122.25 crore during the previous quarter ended March 2023. Sales rose 19.53% to Rs 1054.08 crore in the quarter ended March 2024 as against Rs 881.84 crore during the previous quarter ended March 2023.

For the full year,net profit rose 38.81% to Rs 816.17 crore in the year ended March 2024 as against Rs 587.98 crore during the previous year ended March 2023. Sales rose 12.45% to Rs 4208.71 crore in the year ended March 2024 as against Rs 3742.64 crore during the previous year ended March 2023.

Powered by Capital Market - Live News